Abstracts tagged "tuberculosis and anti-TNF therapy"

Abstract Number: 1696 • ACR/ARP Annual Meeting 2019
Is the Risk of Tuberculosis Increased in Behçet’s Disease Compared to Other Rheumatological Disorders After Anti-TNF-α Treatment?
Ummugulsum Gazel ¹, Derya Kocakaya ², Irem Topcu ³, Hakan Karatas ⁴, Murat Karabacak ⁵, Pamir Atagunduz ⁶, Nevsun Inanc ⁷, Fatma Alibaz-Oner ⁵ and Haner Direskeneli⁸, ¹Marmara University, Faculty of Medicine, Department of Rheumatology, Istanbul, Turkey, Istanbul, Turkey, ²Marmara University Faculty of Medicine Department of Chest Diseases, Istanbul, Turkey, Istanbul, Istanbul, Turkey, ³Marmara University, School of Medicine, Istanbul,Turkey, ıstanvul, Turkey, ⁴Marmara University ,School of Medicine, Istanbul,Turkey, Istanbul, Turkey, ⁵Marmara University Faculty of Medicine,Department of Rheumatology,Istanbul,Turkey, Istanbul, Turkey, ⁶Marmara University Faculty of Medicine,Department of Rheumatology, Istanbul, Turkey, Istanbul, Turkey, ⁷Marmara University, Faculty of Medicine, Division of Rheumatology, Istanbul, Turkey, ISTANBUL, Turkey, ⁸Marmara University, School of Medicine, Division of Rheumatology, Istanbul, Turkey
Background/Purpose: Tumor necrosis factor (TNF)-α inhibitors are extensively utilized in the treatment of inflammatory rheumatic diseases. These agents increase the risk of tuberculosis (TB), especially…